Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5617 - 5624 of 12017 results
“A New Day” for Amending Claims in Post-Grant Proceedings
October 29, 2018| Blog| Viewpoint
Proposed changes to Medicare Advantage audits could put insurers on the hook for billions
October 29, 2018| News
Federal Circuit Denies RPX’s Request for en banc Review in Applications in Internet Time v. RPX
October 26, 2018| Blog| Viewpoint
OIG Publishes Study on Claim and Payment Denials by Medicare Advantage Organizations
October 26, 2018| Blog| Viewpoint
Six Things to Know About the New Section 1332 Waiver Guidance
October 25, 2018| Blog| Viewpoint
NYC Employers Must Engage in "Cooperative Dialogue" on Accommodation Requests
October 25, 2018| Blog| Viewpoint
Strategies to Unlock AI's Potential in Health Care, Part 3: HIPAA and Other Privacy Considerations
October 25, 2018| Blog| Viewpoint
What to Do When Your New Home Is a Lemon
October 25, 2018| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|